Knowing something is broken and choosing not to fix it isn’t a resource decision. It’s a business model decision ...
In the AI value chain, application-layer leaders like Palantir and ServiceNow may win long term as chip/cloud margins ...
Anthropic, OpenAI, the Vatican and Congress all agree AI needs guardrails—but they disagree on what should be protected first ...
As the AI computing race accelerates and semiconductor manufacturing capacity is increasingly redirected toward advanced ...
Chief Brand Officer Mark Pritchard makes the case for the importance of human creativity in building brands in an ...
Q1 2026 saw heightened volatility as fundamental and technical concerns shocked private credit funds, amid a backdrop of ...
It might seem like a casino is a great place to earn extra money. After all, with a little luck, you can multiply your “invested” money many times over. However, almost all forms of gambling have ...
As AI-generated content becomes cheaper and more realistic, strategists warn disclosure requirements alone won't preserve ...
Trillions of SHIB exit exchanges after a record Q2 loss, XRP defends $1 quarterly base, and Citi cuts its Bitcoin target as AI pulls capital from crypto ETFs.
Pharmaceutical Technology on MSN
Beyond the GLP-1RA weight loss ceiling
Eli Lilly’s retatrutide has crossed the 30% weight loss benchmark in some patients. Where do GLP-1RAs go from here?
The way we do business is transforming rapidly. Climate, people, technology, and supply chains have all seen unprecedented momentum toward change. Adapting companies, strategies, and processes to the ...
Non-model organisms are organisms that have not been selected by the research community for extensive study either for historic reasons, or because they lack the features that make model organisms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results